Steven Cohen Heron Therapeutics, Inc. Transaction History

Point72 Asset Management, L.P.

$40.1 Billion
Q1 2025

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 4,775,877 shares of HRTX stock, worth $9.74 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

4,775,877

Previous 3,075,809 55.27%

Holding current value

$9.74 Million

Previous $4.71 Million 123.29%

% of portfolio

0.03%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$1.47 - $2.55 $2.5 Million - $4.34 Million	1,700,068 Added 55.27%	4,775,877 $10.5 Million
Q4 2024 Feb 14, 2025	BUY	$1.06 - $2.12 $3.26 Million - $6.52 Million	3,075,809 New	3,075,809 $4.71 Million
Q1 2024 May 15, 2024	BUY	$1.71 - $3.06 $9,576 - $17,136	5,600 New	5,600 $15,000
Q2 2023 Aug 14, 2023	SELL	$1.11 - $2.88 $37,753 - $97,954	-34,012 Reduced 99.94%	22 $0
Q1 2023 May 15, 2023	BUY	$1.51 - $3.25 $51,391 - $110,610	34,034 New	34,034 $51,000
Q4 2021 Feb 14, 2022	SELL	$8.35 - $12.6 $13.4 Million - $20.2 Million	-1,600,486 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$10.13 - $15.0 $13.7 Million - $20.4 Million	1,357,037 Added 557.42%	1,600,486 $17.1 Million
Q2 2021 Aug 16, 2021	BUY	$13.27 - $18.48 $2.37 Million - $3.3 Million	178,449 Added 274.54%	243,449 $3.78 Million
Q1 2021 May 17, 2021	SELL	$14.49 - $20.72 $657,585 - $940,315	-45,382 Reduced 41.11%	65,000 $1.05 Million
Q4 2020 Feb 16, 2021	SELL	$14.61 - $22.14 $2.21 Million - $3.34 Million	-150,959 Reduced 57.76%	110,382 $2.34 Million
Q3 2020 Nov 16, 2020	BUY	$13.67 - $17.77 $3.57 Million - $4.64 Million	261,341 New	261,341 $3.87 Million
Q2 2019 Aug 14, 2019	SELL	$16.93 - $26.22 $2.94 Million - $4.55 Million	-173,700 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$23.15 - $28.34 $4.02 Million - $4.92 Million	173,700 New	173,700 $4.25 Million
Q3 2018 Nov 14, 2018	SELL	$30.0 - $40.85 $600,000 - $817,000	-20,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$26.4 - $42.0 $528,000 - $840,000	20,000 New	20,000 $777,000

Others Institutions Holding HRTX

# of Institutions

182

Shares Held

125M

Call Options Held

847K

Put Options Held

47.7K

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $242M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account